Uğur Şahin
#96,957
Most Influential Person Now
German oncologist
Uğur Şahin's AcademicInfluence.com Rankings
Uğur Şahinmedical Degrees
Medical
#1270
World Rank
#1592
Historical Rank
Oncology
#54
World Rank
#57
Historical Rank
Uğur Şahinbiology Degrees
Biology
#5381
World Rank
#7845
Historical Rank
Immunology
#269
World Rank
#280
Historical Rank
Download Badge
Medical Biology
Uğur Şahin's Degrees
- Doctorate Medicine University of Cologne
- PhD Immunology University of Cologne
Why Is Uğur Şahin Influential?
(Suggest an Edit or Addition)According to Wikipedia, Uğur Şahin is a German oncologist and immunologist. He is the founder and CEO of BioNTech, which developed one of the major vaccines against COVID-19. His main fields of research are cancer research and immunology.
Uğur Şahin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine (2020) (7900)
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates (2020) (1707)
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer (2017) (1500)
- A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. (1997) (1278)
- mRNA-based therapeutics — developing a new class of drugs (2014) (1163)
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses (2020) (1143)
- Human neoplasms elicit multiple specific immune responses in the autologous host. (1995) (1115)
- Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (2020) (1069)
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy (2016) (1020)
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer (2015) (895)
- Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices (1999) (759)
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months (2021) (727)
- Exploiting the mutanome for tumor vaccination. (2012) (668)
- A vaccine targeting mutant IDH1 induces antitumour immunity (2014) (576)
- Personalized vaccines for cancer immunotherapy (2018) (541)
- Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents (2021) (527)
- Actively personalized vaccination trial for newly diagnosed glioblastoma (2018) (518)
- Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera (2021) (484)
- BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans (2021) (413)
- Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. (2006) (413)
- Characterization of human colon cancer antigens recognized by autologous antibodies (1998) (354)
- Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. (1998) (350)
- BNT162b vaccines protect rhesus macaques from SARS-CoV-2 (2021) (339)
- Serological identification of human tumor antigens. (1997) (336)
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma (2020) (332)
- Neutralizing Activity of BNT162b2-Elicited Serum (2021) (322)
- D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization (2020) (296)
- Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age (2021) (290)
- Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. (1998) (287)
- BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants (2021) (281)
- The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. (1996) (272)
- Autoantibodies in breast cancer: their use as an aid to early diagnosis. (2007) (263)
- Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses (2017) (255)
- SSX: A multigene family with several members transcribed in normal testis and human cancer (1997) (250)
- Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. (2010) (246)
- Molecular Definition of a Novel Human Galectin Which Is Immunogenic in Patients with Hodgkin's Disease* (1997) (243)
- Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma (2014) (242)
- SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 (2021) (240)
- Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera (2022) (238)
- Serological analysis of human tumor antigens: molecular definition and implications. (1997) (233)
- Autoantibodies in lung cancer: possibilities for early detection and subsequent cure (2007) (220)
- A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors (2012) (220)
- Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. (2000) (216)
- Expression of SSX genes in human tumors (1998) (192)
- An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors (2020) (190)
- HLA typing from RNA-Seq sequence reads (2012) (189)
- Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development (2008) (187)
- Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells. (1994) (180)
- RNA-Seq Atlas - a reference database for gene expression profiling in normal tissue by next-generation sequencing (2012) (172)
- Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo (2010) (168)
- Myeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis. (2017) (167)
- A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA (2019) (162)
- A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis (2021) (159)
- BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans (2020) (154)
- Neutralizing Activity of BNT162b2-Elicited Serum - Preliminary Report. (2021) (149)
- Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation (2011) (146)
- Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. (1997) (145)
- RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study (2020) (140)
- Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies (1998) (136)
- Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening. (2019) (135)
- An RNA toolbox for cancer immunotherapy (2018) (133)
- Elimination of large tumors in mice by mRNA-encoded bispecific antibodies (2017) (132)
- An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. (2016) (131)
- Proteasome-Assisted Identification of a SSX-2-Derived Epitope Recognized by Tumor-Reactive CTL Infiltrating Metastatic Melanoma1 (2002) (130)
- Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. (2002) (128)
- Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report (2020) (126)
- Tumor vaccination using messenger RNA: prospects of a future therapy. (2011) (124)
- Expression of cancer testis genes in human brain tumors. (2000) (123)
- Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine (2021) (122)
- A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates (2020) (113)
- Robinia pseudo-acacia L. as a possible biomonitor of heavy metal pollution in Kayseri (2000) (110)
- Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals1 (2008) (105)
- A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform (2015) (102)
- Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines (2016) (99)
- FAST: A randomised phase II study of zolbetuximab (IMAB362) plus EOX vs EOX alone for first-line treatment of advanced CLDN18.2 positive gastric and gastro-oesophageal adenocarcinoma. (2021) (99)
- Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK. (2013) (96)
- A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes. (2007) (96)
- Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine (2022) (95)
- mRNA therapeutics in cancer immunotherapy (2021) (92)
- Spectrophotometric determination of molybdenum in steel samples utilizing selective sorbent extraction on Amberlite XAD-8 resin (1996) (92)
- A CD16/CD30 bispecific monoclonal antibody induces lysis of hodgkin's cells by unstimulated natural killer cells In AND In vivo (1993) (91)
- Cascades of transcriptional induction during dendritic cell maturation revealed by genome‐wide expression analysis (2003) (91)
- Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study (2021) (87)
- Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine (2020) (86)
- Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid‐like nanoparticles resolves liver fibrosis (2015) (86)
- Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. (2006) (79)
- BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants (2021) (78)
- Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes (2022) (77)
- Tumor-associated CpG demethylation augments hypoxia-induced effects by positive autoregulation of HIF-1α (2011) (75)
- A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines (2014) (74)
- Determination of Fluoride in Various Samples and Some Infusions Using a Fluoride Selective Electrode (2004) (71)
- Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma. (2016) (69)
- Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer (2014) (69)
- A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study (2019) (68)
- 24 Combined analysis of antigen presentation and T cell recognition reveals restricted immune responses in melanoma (2018) (68)
- OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation (2020) (67)
- A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity. (2020) (67)
- MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes. (2008) (67)
- Determination of trace amounts of some metals in samples with high salt content by atomic absorption spectrometry after cobalt-diethyldithiocarbamate coprecipitation. (1997) (66)
- Identification of neoantigens for individualized therapeutic cancer vaccines (2022) (66)
- FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines. (2011) (66)
- HLA and proteasome expression body map (2018) (65)
- mRNA as a versatile tool for exogenous protein expression. (2012) (62)
- Elaeagnus angustifolia L. as a Biomonitor of Heavy Metal Pollution (1999) (62)
- Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibody. (1990) (62)
- Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma (2016) (60)
- Correction: Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals (2012) (60)
- A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing (2002) (60)
- The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines (2022) (60)
- Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond (2015) (59)
- A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer. (2018) (58)
- Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model (2020) (58)
- Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population (2018) (58)
- ERBB2-Mediated Transcriptional Up-regulation of the α5β1 Integrin Fibronectin Receptor Promotes Tumor Cell Survival Under Adverse Conditions (2006) (58)
- Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion. (2015) (58)
- The regulatory landscape for actively personalized cancer immunotherapies (2013) (58)
- The role of lymphocyte subsets and adhesion molecules in T cell‐dependent cytotoxicity mediated by CD3 and CD28 bispecific monoclonal antibodies (1995) (57)
- IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines (2021) (56)
- FAST: An international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without IMAB362, a first-in-class anti-CLDN18.2 antibody, as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adenocarcinoma (2016) (56)
- Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA (2018) (56)
- Mutanome directed cancer immunotherapy. (2016) (56)
- Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms (2014) (55)
- Definition of tumor-associated antigens in hepatocellular carcinoma. (2000) (54)
- Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice (2016) (54)
- Frequent Nonrandom Activation of Germ-Line Genes in Human Cancer (2004) (53)
- Targeting the tumor mutanome for personalized vaccination therapy (2012) (53)
- Genome-Based In Silico Identification of New Mycobacterium tuberculosis Antigens Activating Polyfunctional CD8+ T Cells in Human Tuberculosis (2011) (52)
- An on-line preconcentration/separation system for the determination of bismuth in environmental samples by FAAS. (2010) (52)
- Highly specific auto-antibodies against claudin-18 isoform 2 induced by a chimeric HBcAg virus-like particle vaccine kill tumor cells and inhibit the growth of lung metastases. (2011) (51)
- Tailoring the stealth properties of biocompatible polysaccharide nanocontainers. (2015) (50)
- Polysarcosine-Functionalized Lipid Nanoparticles for Therapeutic mRNA Delivery (2020) (50)
- Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens. (1999) (50)
- TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression (2015) (49)
- NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells (2016) (49)
- Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals. (2011) (49)
- Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer (2006) (48)
- Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes (2014) (46)
- Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA (2007) (45)
- Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential (2016) (45)
- The Wnt/β-Catenin Pathway Attenuates Experimental Allergic Airway Disease (2014) (45)
- Synthetic mRNAs with superior translation and stability properties. (2013) (43)
- Edge detection with fuzzy cellular automata transition function optimized by PSO (2015) (43)
- Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens (2016) (42)
- Development of a new on-line system for the sequential speciation and determination of chromium species in various samples using a combination of chelating and ion exchange resins. (2014) (42)
- Computational dissection of tissue contamination for identification of colon cancer‐specific expression profiles (2003) (42)
- RP1, a new member of the adenomatous polyposis coli-binding EB1-like gene family, is differentially expressed in activated T cells. (1997) (41)
- Expression profiling of autoimmune regulator AIRE mRNA in a comprehensive set of human normal and neoplastic tissues. (2006) (40)
- Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines. (2019) (40)
- mTOR Inhibition Improves Antitumor Effects of Vaccination with Antigen-Encoding RNA (2013) (40)
- Salt and pepper noise filtering with fuzzy-cellular automata (2014) (40)
- Expression of serologically identified tumor antigens in acute leukemias. (2003) (40)
- Supplier selection using activity‐based costing and fuzzy present‐worth techniques (2003) (39)
- CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer (2015) (39)
- Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA (2020) (39)
- Cure of disseminated xenografted human Hodgkin's tumors by bispecific monoclonal antibodies and human T cells: the role of human T-cell subsets in a preclinical model. (1996) (39)
- ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions. (2006) (39)
- Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma (2019) (38)
- HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory (2019) (38)
- Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma* (2018) (38)
- Instruction of haematopoietic lineage choices, evolution of transcriptional landscapes and cancer stem cell hierarchies derived from an AML1-ETO mouse model (2013) (37)
- Induction of immunosuppressive functions and NF-κB by FLIP in monocytes (2018) (37)
- Mutated tumor alleles are expressed according to their DNA frequency (2014) (37)
- Complex Cellular Responses of Helicobacter pylori-Colonized Gastric Adenocarcinoma Cells (2011) (37)
- Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins (2017) (36)
- Selective Activation of Trophoblast-specific PLAC1 in Breast Cancer by CCAAT/Enhancer-binding Protein β (C/EBPβ) Isoform 2* (2009) (36)
- Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside (2014) (36)
- Pattern recognition with surface EMG signal based wavelet transformation (2012) (36)
- Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6 (2015) (35)
- Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics (2011) (34)
- Identification of tumor-associated autoantigens with SEREX. (2005) (33)
- Local delivery of mRNA-encoding cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models (2021) (33)
- CD30‐antigen‐specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: Potential use for the treatment of hodgkin's lymphoma (1993) (33)
- Functional TCR Retrieval from Single Antigen-Specific Human T Cells Reveals Multiple Novel Epitopes (2014) (33)
- mRNA: A Versatile Molecule for Cancer Vaccines. (2017) (33)
- Galaxy LIMS for next-generation sequencing (2013) (33)
- Steatohepatitis Impairs T cell-directed Immunotherapies Against Liver Tumors in Mice. (2020) (32)
- Characterization of zolbetuximab in pancreatic cancer models (2018) (32)
- An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper® (2017) (32)
- DLLME-spectrophotometric determination of glyphosate residue in legumes. (2017) (32)
- An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells (2016) (32)
- Confidence-based Somatic Mutation Evaluation and Prioritization (2012) (31)
- A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study. (2019) (31)
- Cystine‐knot peptides targeting cancer‐relevant human cytotoxic T lymphocyte‐associated antigen 4 (CTLA‐4) (2015) (31)
- Molecular Characterization of Virus-induced Autoantibody Responses (2004) (31)
- Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry (2016) (31)
- Investigation of charge ratio variation in mRNA - DEAE-dextran polyplex delivery systems. (2019) (30)
- The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexes. (2006) (29)
- Potassium Abnormalities in Current Clinical Practice: Frequency, Causes, Severity and Management (2015) (29)
- In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET (2018) (28)
- Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes (2016) (27)
- Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2 (2009) (27)
- Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection (2022) (27)
- Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates (2021) (26)
- NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells (2013) (26)
- Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination (2015) (25)
- Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses (2021) (25)
- Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols (2012) (25)
- Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles (2017) (25)
- Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors (1996) (25)
- SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity. (2003) (24)
- Determination of Copper(II) using atomic absorption spectrometry and eriochrome blue black R loaded amberlite XAD-1180 resin. (2010) (24)
- Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5 (2022) (24)
- Hodgkin and Reed-Sternberg cell-associated autoantigen CLIP-170/restin is a marker for dendritic cells and is involved in the trafficking of macropinosomes to the cytoskeleton, supporting a function-based concept of Hodgkin and Reed-Sternberg cells. (2002) (24)
- Final results of the FAST study, an international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adeno (2016) (24)
- Determination of Aluminum at Trace Level in Water Samples by Visible Absorption Spectroscopy with a Laser Diode (1997) (23)
- The synthesis of isopropylidene mRNA cap analogs modified with phosphorothioate moiety and their evaluation as promoters of mRNA translation. (2013) (22)
- Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide (2018) (22)
- Challenges towards the realization of individualized cancer vaccines (2018) (22)
- A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice (2020) (22)
- Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors. (2020) (22)
- Identification of new claudin family members by a novel PSI‐BLAST based approach with enhanced specificity (2006) (22)
- Determination of Fluoride and Some Metal Ion Levels in the Drinking Waters in Kayseri Province (2001) (22)
- Three-state von Neumann cellular automata and pattern generation (2015) (22)
- Zolbetuximab combined with EOX as first-line therapy in advanced CLDN18.2+ gastric (G) and gastroesophageal junction (GEJ) adenocarcinoma: Updated results from the FAST trial. (2019) (22)
- rapmad: Robust analysis of peptide microarray data (2011) (21)
- Elaeagnus angustifoliaL. as a Biomonitor of Heavy Metal Pollution (1999) (21)
- The European Regulatory Environment of RNA-Based Vaccines. (2017) (20)
- Harvesting of blooming microalgae using green synthetized magnetic maghemite (γ-Fe2O3) nanoparticles for biofuel production (2019) (20)
- An overview of hematopoietic stem cell transplantation related thrombotic complications. (2016) (20)
- Incorporation of mRNA in Lamellar Lipid Matrices for Parenteral Administration. (2017) (19)
- Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (2021) (19)
- BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2 (2020) (19)
- Association of breast cancer subtypes and body mass index. (2013) (19)
- Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial (2021) (19)
- Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice. (2018) (19)
- Improved Neutralization of Omicron BA.4/5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent BA.4/5 Vaccine (2022) (19)
- Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation (2018) (19)
- Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studies. (2013) (18)
- Molecular characterization of virus-induced autoantibody responses. (2004) (18)
- Treatment of Hodgkin's disease with bispecific antibodies. (1996) (17)
- Autoimmunity seen through the SEREX-scope. (2003) (17)
- TN-RSI: Trend-normalized RSI Indicator for Stock Trading Systems with Evolutionary Computation (2014) (17)
- A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults (2021) (17)
- Self-Replicating Patterns in 2D Linear Cellular Automata (2014) (17)
- NF‐κB factors control the induction of NFATc1 in B lymphocytes (2014) (17)
- Leachate removal rate and the effect of leachate on the hydraulic conductivity of natural (undisturbed) clay (2006) (16)
- Abstract CT301: A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors (2020) (16)
- Bioactivity and mineral contents of wild-grown edible Morchella conica in the Mediterranean Region (2010) (16)
- In Silico HLA Typing Using Standard RNA-Seq Sequence Reads. (2015) (16)
- Determination of heavy metals at sub-ppm levels in seawater and dialysis solutions by FAAS after tetrakis(pyridine)-nickel(II)bis(thiocyanate) coprecipitation. (2008) (16)
- A new automated system for the determination of Al(III) species in dialysis concentrates by electrothermal atomic absorption spectrometry using a combination of chelating resin (2015) (16)
- Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells (2017) (15)
- CrELISA: a fast and robust enzyme-linked immunosorbent assay bypassing the need for purification of recombinant protein. (2004) (15)
- On the irreversibility of Moore cellular automata over the ternary field and image application (2016) (15)
- Humoral immune responses of lung cancer patients against the Transmembrane Phosphatase with TEnsin homology (TPTE). (2015) (15)
- Safety, tolerability, and efficacy of the first-in-class antibody IMAB362 targeting claudin 18.2 in patients with metastatic gastroesophageal adenocarcinomas. (2013) (15)
- First-in-human phase I/II dose-escalation study of IMAB027 in patients with recurrent advanced ovarian cancer (OVAR): Preliminary data of phase I part. (2015) (15)
- An automated on-line minicolumn preconcentration cold vapour atomic absorption spectrometer: application to determination of cadmium in water samples. (2012) (15)
- Dexamethasone premedication suppresses vaccine-induced immune responses against cancer (2020) (14)
- Rapid molecular dissection of viral and bacterial immunomes (2006) (14)
- Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell response (2019) (14)
- Investigation of pH-Responsiveness inside Lipid Nanoparticles for Parenteral mRNA Application Using Small-Angle X-ray Scattering. (2020) (14)
- Uniform Cellular Automata Linear Rules for Edge Detection (2013) (13)
- More than a Virus: How COVID 19 Infected Education in Turkey?. (2020) (13)
- Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources. (1994) (13)
- Real-Time Monitoring of Indigo Concentrations in the Dyebath with a Laser Diode Spectrometer (2004) (13)
- GAPVAC-101: First-in-human trial of a highly personalized peptide vaccination approach for patients with newly diagnosed glioblastoma. (2018) (12)
- Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes (2020) (12)
- Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma (2018) (12)
- Bivalent Omicron BA.1–Adapted BNT162b2 Booster in Adults Older than 55 Years (2023) (12)
- 636PEFFICACY AND SAFETY OF MULTIPLE DOSES OF IMAB362 IN PATIENTS WITH ADVANCED GASTRO-ESOPHAGEAL CANCER: RESULTS OF A PHASE II STUDY. (2014) (12)
- 88MO T-cell responses induced by an individualized neoantigen specific immune therapy in post (neo)adjuvant patients with triple negative breast cancer (2020) (12)
- Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma* (2019) (12)
- Trace elements in blood samples of smoker and nonsmoker active pulmonary tuberculosis patients from Jamshoro, Pakistan (2017) (11)
- An automated solid phase extraction coupled with electrothermal atomic absorption spectrometric determination of Pb(II) in high salt content samples. (2011) (11)
- Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors (2022) (11)
- IMAB362 plus zoledronic acid (ZA) and interleukin-2 (IL-2) in patients (pts) with advanced gastroesophageal cancer (GEC): Clinical activity and safety data from the PILOT phase I trial. (2015) (11)
- Early computational detection of potential high-risk SARS-CoV-2 variants (2021) (11)
- On-line determination of palladium by flame atomic absorption spectrometry coupled with a separation/preconcentration minicolumn containing a new sorbent (2013) (11)
- Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer (2015) (11)
- IMPROVED DELAY-DEPENDENT ROBUST STABILIZATION OF SINGULAR SYSTEMS (2010) (11)
- T-cell receptor transfer into human T cells with ecotropic retroviral vectors (2014) (10)
- Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy (2019) (10)
- Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma (2021) (10)
- BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19 (2021) (10)
- Serum and urine boron and selenium levels in children with resistant epilepsy. (2012) (10)
- 2D Cellular Automata with an Image Processing Application (2014) (10)
- Is there a role of high dose chemotherapy and autologous stem cell transplantation in the treatment of Ewing's sarcoma and osteosarcomas? (2018) (10)
- Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. (2018) (10)
- A Fuzzy Model Approach to Stress–Strain Relationship of Concrete in Compression (2014) (10)
- A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo (2019) (10)
- Determination of trace metals in water samples by flame atomic absorption spectrometry after co-precipitation with ion In(OH) 3 (2005) (9)
- 378PPreclinical characterization of IMAB362 for the treatment of gastric carcinoma (2017) (9)
- On-line solid-phase separation/preconcentration for the determination of copper in urine by flame atomic absorption spectrometry. (2014) (9)
- Abstract CT169: A phase Ia study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in patients with locally advanced or metastatic solid tumors (2020) (9)
- Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. (2019) (9)
- Abstract CT156: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma (2018) (9)
- Allogeneic stem cell transplantation for relapsed primary central nervous system lymphoma: Is it feasible? (2019) (9)
- The Transition Rules of 2D Linear Cellular Automata Over Ternary Field and Self-Replicating Patterns (2015) (9)
- Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the Mutanome. (2017) (8)
- Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine (2023) (8)
- Current Developments in Actively Personalized Cancer Vaccination with a Focus on RNA as the Drug Format. (2015) (8)
- Abstract OT2-06-01: Highly innovative personalized RNA-immunotherapy for patients with triple negative breast cancer (2019) (8)
- Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competence (2017) (8)
- Targeting the tumor vasculature with engineered cystine-knot miniproteins (2020) (8)
- Trace elements in children suffering from idiopathic nephrotic syndrome. (2014) (8)
- Studying Tumor-ReacTive T Cells: A Personalized Organoid Model. (2018) (8)
- Neutralization of SARS-CoV-2 variants B.1.617.1 and B.1.525 by BNT162b2-elicited sera (2021) (8)
- Block Matching with Particle Swarm Optimization for Motion Estimation (2013) (8)
- The Wnt/b-Catenin Pathway Attenuates Experimental Allergic Airway Disease (2014) (7)
- 391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab in advanced solid tumors (2020) (7)
- Abstract CT032: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent cancer immunotherapy in patients with malignant melanoma (2016) (7)
- FLT3 Ligand as a Molecular Adjuvant for Naked RNA Vaccines. (2016) (7)
- Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens (2022) (7)
- Determination of Aluminum in Dialysis Concentrates by Atomic Absorption Spectrometry after Coprecipitation with Lanthanum Phosphate (2017) (7)
- Displaying Tetra-Membrane Spanning Claudins on Enveloped Virus-Like Particles for Cancer Immunotherapy. (2018) (7)
- Antigen identification using SEREX. (2013) (7)
- Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice (2022) (7)
- Generation of TCR-Engineered T Cells and Their Use To Control the Performance of T Cell Assays (2015) (7)
- Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma (2019) (7)
- A shared tumor-antigen RNA-lipoplex vaccine with/without anti-PD1 in patients with checkpoint-inhibition experienced melanoma. (2020) (6)
- Luciferase mRNA Transfection of Antigen Presenting Cells Permits Sensitive Nonradioactive Measurement of Cellular and Humoral Cytotoxicity (2016) (6)
- Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes (2022) (6)
- Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer (2021) (6)
- Recognition of human tumors: SEREX expression cloning to identify tumour antigens (2001) (6)
- Omicron breakthrough infection drives cross-variant neutralization and memory B cell formation (2022) (6)
- 49PA first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunotherapy (2017) (6)
- The relationship between metabolic bone diseases and fingernail calcium levels in the elderly (2012) (6)
- Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans (2018) (6)
- In Silico Typing of Classical and Non-classical HLA Alleles from Standard RNA-Seq Reads. (2018) (6)
- Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy (2020) (6)
- Hybridized fuzzy cellular automata thresholding algorithm for edge detection optimized by PSO (2013) (6)
- Abstract LB-130: Combinatorial treatment with intratumoral cytokine mRNAs results in high frequency of tumor rejection and development of anti-tumor immunity across a range of preclinical cancer models (2018) (5)
- Prognosis of breast cancer in patients with peritoneal metastasis. (2012) (5)
- Subsequent malignancies after allogeneic hematopoietic stem cell transplantation (2017) (5)
- Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance. (2018) (5)
- PLAC1 is essential for FGF7/FGFRIIIb-induced Akt-mediated cancer cell proliferation (2020) (5)
- Peptide microarrays enable rapid mimotope optimization for pharmacokinetic analysis of the novel therapeutic antibody IMAB362. (2014) (5)
- Ribozyme Assays to Quantify the Capping Efficiency of In Vitro-Transcribed mRNA (2022) (5)
- Personalized Neo-Epitope Vaccines for Cancer Treatment. (2020) (5)
- A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections (2022) (5)
- Expression of Claudin 18.2 and HER2 in gastric, gastroesophageal junction, and esophageal cancers: Results from the FAST study. (2017) (5)
- First report demonstrating the safety and immunogenicity of the SARS-COV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, observer-blind Phase I study (2021) (4)
- Abstract 1728: Nonalcoholic steatohepatitis (NASH) impairs treatment of intrahepatic metastases with CD4+T cell dependent RNA vaccine (2018) (4)
- Integrative analysis of structural variations using short-reads and linked-reads yields highly specific and sensitive predictions (2020) (4)
- Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. (2019) (4)
- A Case of Superwarfarin Poisoning Due to Repetitive Occupational Dermal Rodenticide Exposure in a Worker (2016) (4)
- Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA (2021) (4)
- Transferring a Quantitative Molecular Diagnostic Test to Multiple Real-Time Quantitative PCR Platforms. (2018) (4)
- Review of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in solid tumors excluding breast cancer (2016) (4)
- Circulating levels of ghrelin, galanin, and orexin-A orexigenic neuropeptides in obstructive sleep apnea syndrome (2021) (4)
- 412 First-in-human phase I/IIa trial to evaluate the safety and initial clinical activity of DuoBody®-PD-L1×4–1BB (GEN1046) in patients with advanced solid tumors (2020) (4)
- 376PPreclinical evaluation of the anti-CLDN18.2 antibody, IMAB362, in pancreatic carcinoma (2017) (4)
- Next Generation Immunotherapy (2021) (4)
- Effects of Angiostatin on in vitro Embryonic Rat Development (2011) (4)
- BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants (2021) (4)
- Abstract CT022: IVAC® MUTANOME - A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma (2016) (4)
- 6OIVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma (2017) (4)
- How to transfer a quantitative molecular diagnostic test to multiple qPCR platforms (2018) (3)
- Abstract CT034: A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles for potent melanoma immunotherapy (2017) (3)
- Abstract B041: A novel nanoparticular formulated tetravalent RNA cancer vaccine for treatment of patients with malignant melanoma (2016) (3)
- Abstract 882: The anti-claudin 6 antibody, IMAB027, induces antibody-dependent cellular and complement-dependent cytotoxicity in claudin 6-expressing cancer cells (2018) (3)
- Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction (2014) (3)
- BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants (2022) (3)
- Multifunctional mRNA-based CAR T cells display promising anti-tumor activity against glioblastoma. (2022) (3)
- 421 A first-in-human (FIH) phase I/IIa clinical trial assessing a ribonucleic acid lipoplex (RNA-LPX) encoding shared tumor antigens for immunotherapy of prostate cancer; preliminary analysis of PRO-MERIT (2021) (3)
- Abstract CT221: Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC) (2019) (3)
- Nutritional iodine status of breast-feeding mothers and their neonates in Kayseri. (2009) (3)
- 377PPreclinical characterization of IMAB362-vcMMAE, an anti-CLDN18.2 antibody–drug conjugate (2017) (3)
- An overview of high dose chemotherapy with autologous stem cell rescue for germ cell tumors in current practice. (2017) (3)
- An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation (2022) (3)
- DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity (2022) (3)
- mRNA Vaccination and Personalized Cancer Therapy (2014) (3)
- NeoFox: annotating neoantigen candidates with neoantigen features (2021) (3)
- Erratum: Elimination of large tumors in mice by mRNA-encoded bispecific antibodies (2017) (3)
- ArtiFuse - computational validation of fusion gene detection tools without relying on simulated reads (2019) (3)
- Chromatin Immunoprecipitation Assay to Identify Genomic Binding Sites of Regulatory Factors. (2016) (3)
- Graft-versus-cancereffect and innovative approaches in the treatment of refractorysolid tumors (2020) (3)
- Abstract CT202: IVAC MUTANOME: Individualized vaccines for the treatment of cancer (2015) (3)
- Determination of 3,5 - dimethylpyrazolium glyceroborate nitrification inhibitor in nitrogen fertilizer samples: HPLC-DAD method development and validation for 3,5 - dimethylpyrazole. (2017) (3)
- Investigation of the clonal associations in Acinetobacter Baumannii strains isolated from the respiratory samples of patients in a tertiary research hospital (2020) (3)
- Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies (2019) (2)
- Abstract CT002: BNT211: A Phase I trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors (2022) (2)
- Highlighting the Prognostic Importance of Measurable Residual Disease Amongst Acute Myeloid Leukemia Risk Factors (2020) (2)
- Abstract 4451: Combination of local mRNA immunotherapy with systemic immune checkpoint blockade demonstrates anti-tumor activity across a diverse range of preclinical syngeneic tumor models (2020) (2)
- Determination of total phosphorus in milk by near-infrared absorption spectroscopy with laser diode (2005) (2)
- Computation of grade values of sediment-hosted barite deposits in northeastern Isparta ( western Turkey ) (2013) (2)
- Future Perspectives for Haploidentical SCT (2017) (2)
- 561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation (2020) (2)
- Computation of grade values of sediment-hosted barite deposits in northeastern Isparta (western Turkey) (2013) (2)
- Inflammatory markers in metastatic breast cancer. (2013) (2)
- Looking for more reliable biomarkers in breast cancer: Comparison between routine methods and RT-qPCR (2021) (2)
- Comparison of clinicopathological characteristics and outcome of younger and older breast cancer patients. (2012) (2)
- Exposure to BA.4/BA.5 Spike glycoprotein drives pan-Omicron neutralization in vaccine-experienced humans and mice (2022) (2)
- Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (2021) (2)
- Development of a 635 nm-Laser Diode Spectrometer for Continuous Monitoring of Amino Nitrogen in the Beet Sugar Industry (2009) (2)
- 958 BNT211: a phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumors (2021) (2)
- Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC). (2018) (2)
- Mutanome Engineered RNA Immunotherapy (MERIT). (2015) (2)
- Liposome-Encapsulated Adjuvants are Potent Inducers of Antigen- Specific T-Cells in Vivo (2008) (2)
- The End of a Long Debate: Methylenetetrahydrofolate Reductase Gene Polymorphisms do not Increase Thrombosis Risk. (2017) (2)
- Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial (2022) (2)
- Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapies (2015) (2)
- Comprehensive Genomic and Transcriptomic Analysis of Three Synchronous Primary Tumours and a Recurrence from a Head and Neck Cancer Patient (2021) (2)
- Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue (2018) (2)
- mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2 (2022) (2)
- Actively personalized cancer vaccines--the step into clinical application. (2016) (2)
- 549 An RNA-lipoplex (RNA-LPX) vaccine demonstrates strong immunogenicity and promising clinical activity in a Phase I trial in cutaneous melanoma patients with no evidence of disease at trial inclusion (2021) (2)
- Does the sequence of taxane administration affect the outcome of patients with breast cancer in the adjuvant and neoadjuvant settings? (2010) (1)
- Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population (2018) (1)
- LB20 - Heparin enhances CD34+ content of stem cells collected following G-CSF +/- chemotherapy (2017) (1)
- HLA-C restricted neoepitopes contribute significantly to the immune recognition of cancer (2019) (1)
- Actively personalized vaccination trial for newly diagnosed glioblastoma (2018) (1)
- Corrigendum: NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells (2016) (1)
- Identification of Human Tumor Antigens Using the B-Cell Repertoire (1998) (1)
- Peptide-MHC Structure Prediction With Mixed Residue and Atom Graph Neural Network (2022) (1)
- Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma (2014) (1)
- Abstract IA06: Targeting the mutanome for individualized cancer immunotherapy (2016) (1)
- Abstract CT201: The Mutanome Engineered RNA Immuno-Therapy (MERIT) project (2015) (1)
- Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age (2023) (1)
- High Prevalence of Claudin 18.2 Expression in Japanese Patients with Gastric Cancer. (2017) (1)
- BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants (2022) (1)
- A first-in-human dose escalation and dose-finding phase I/II trial of IMAB027 in patients with recurrent advanced ovarian cancer (GM-IMAB-002-01). (2014) (1)
- Abstract P5-10-13: Low influence of tumor cell content on mRNA expression levels of ESR, PGR, HER2 and KI67 when performing the MammaTyper® RT-PCR kit (2015) (1)
- Abstract 1907: Claudin 6 is a carcinoembryonic antigen with cancer stem cell marker features (2018) (1)
- Abstract CT020: MERIT: introducing individualized cancer vaccines for the treatment of TNBC - a phase I trial (2016) (1)
- Impact of obesity in postmenopausal early breast cancer patients receiving frontline adjuvant aromatase inhibitors. (2012) (1)
- Abstract 2903: IMAB362, a novel first-in-class monoclonal antibody for treatment of pancreatic cancer (2014) (1)
- Abstract A37: Ectopic claudin 6 and 18.2 expression as potential treatment target in non-small cell lung cancer. (2014) (1)
- Determination of Curcumin in Food with Homogenous Liquid-Phase Microextraction Preconcentration and Spectrophotometric Determination (2022) (1)
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses (2020) (1)
- 664PPhase 1 Study of IMAB362 with immunomodulation in patients with advanced gastric cancer (2017) (1)
- A trans-amplifying RNA simplified to essential elements is highly replicative and robustly immunogenic in mice. (2023) (1)
- A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune Responses (2022) (1)
- Abstract 2654: GAPVAC-101 phase I trial: First data of an innovative actively personalized peptide vaccination trial in patients with newly diagnosed glioblastoma (2016) (1)
- Treatment of organized industrial wastewater by MBR: First results for KOIZ (2017) (1)
- 99TiPMutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (2017) (1)
- Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNA (2021) (1)
- OS2.1 Immune responses to a mutation-specific peptide vaccine targeting IDH1R132H in patients with IDH1R132H-mutated gliomas. (2016) (1)
- A TCR-like CAR Promotes Sensitive Antigen Recognition and Controlled T-cell Expansion Upon mRNA Vaccination (2022) (1)
- P2.06 Exploiting The Mutanome for Tumor Vaccination (2012) (1)
- HLA typing from RNA-Seq sequence reads (2012) (1)
- Immunogenicity and Safety of BNT162b2 mRNA Vaccine in Chinese Adults: A Randomized Clinical Trial (2022) (1)
- Abstract P3-08-14: Prediction of distant recurrence in low risk early breast cancer by RT-qPCR based subtyping using MammaTyper® (2018) (1)
- Abstract LB-383: An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors (2020) (1)
- In silico strategy for detection of target candidates for antibody therapy of solid tumors. (2008) (1)
- An automated system for preconcentration on imprinted polymer and laser diode spectrometric determination of uranium in mineral water samples. (2020) (1)
- Inflammatory markers in early-stage breast cancer. (2013) (1)
- [New perspectives in immunotherapy: adhesion molecules, superantigens, heat-shock proteins and cytokine antagonists]. (2008) (1)
- A Review of Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Breast Cancer (2018) (1)
- IDENTIFICATION OF HUMAN TUMOR ANTIGENS USING THE ANTIBODY REPERTOIRE OF CANCER PATIENTS (1999) (1)
- Early stage “T2N0” breast cancer: Does it consist two different “T2” stages? (2013) (1)
- A Framework for Intelligent Creation of Edge Detection Filters (2015) (1)
- Design of a Wireless Polysomnography System (2020) (1)
- Delay-Dependent Guaranteed Cost Control for T-S Fuzzy Descriptor Systems with Time Varying Delay (2009) (1)
- Abstract B62: Evaluation of systemic RNA-based cancer vaccine induced T-cell responses via mouse T-cell receptor (TCR) profiling (2020) (0)
- MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression (2023) (0)
- An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper® (2017) (0)
- Monoclonal antibodies against claudin-18 for cancer treatment (2006) (0)
- Past, present and future of immunology in Mainz. (2016) (0)
- Plain language summary of Pfizer-BioNTech BNT162b2 vaccine protection against COVID-19 and its safety in participants 12- to 15-years-old (2023) (0)
- Abstract P5-02-01: Comparison of ESR1, PGR, HER2 and KI67 expression by central IHC and MammaTyper® RT-qPCR kit in the FinHer trial (2015) (0)
- Modifications d'arn, qui permettent une stabilite de transcription et une efficacite de translation ameliorees (2006) (0)
- Secure Genome Processing in Public Cloud and HPC Environments (2019) (0)
- 1389 RNA SEQ ATLAS: NGS DATA RESOURCE FOR IDENTIFYING LIVER SPECIFIC GENES (2012) (0)
- Identifying surface-associated antigens for diagnosis and tumor therapy (2006) (0)
- Monoclonal antibodies against GT468 for treating cancer (2008) (0)
- Abstract P1-10-23: Prediction of pathological complete response (pCR) upon neoadjuvant chemotherapy by MammaTyper® pCR score (2020) (0)
- 493 First-in-human phase 1/2 trial to evaluate the safety and initial clinical activity of DuoBody®-CD40×4–1BB (GEN1042) in patients with advanced solid tumors (2021) (0)
- Anticorps utiles dans le diagnostic du cancer (2012) (0)
- Association of Breast Cancer Subtypes and Body Mass Index (2013) (0)
- Correction for Schneider et al., Complex Cellular Responses of Helicobacter pylori-Colonized Gastric Adenocarcinoma Cells (2015) (0)
- Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma (2019) (0)
- Cancer esearch oenvironment and Immunology anodal Vaccination with Naked Antigen-Encoding RNA its Potent Prophylactic and Therapeutic R itumoral Immunity (2010) (0)
- Multiple instance learning to predict immune checkpoint blockade efficacy using neoantigen candidates (2022) (0)
- Determination of Aluminum at Trace Level in Water Visible Absorption Spectroscopy with a Laser Diode Samples by (2006) (0)
- OS2.2 Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial (2018) (0)
- P04.52 Spontaneous intratumoral T cell responses against glioblastoma-associated antigens (2018) (0)
- Abstract 3281: GEN1042 (DuoBody-CD40x4-1BB)®in combination with PD-1 blockade reverses T-cell exhaustion in vitro (2023) (0)
- Using RNA to reprogram somatic cells (2008) (0)
- OS2.6 Identification of IDH1R132H-specific T cell receptors from a humanized mouse model and from glioma patients treated with an IDH1R132H-specific peptide vaccine (2016) (0)
- Process Development for the Identification of Novel Microbodies against NSCLC Related Targets (2017) (0)
- Cancer-associated nucleic acid and proteins (1998) (0)
- Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection. (2022) (0)
- Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma (2019) (0)
- A Fuzzy Model Approach to Stress–Strain Relationship of Concrete in Compression (2014) (0)
- Investigation of the immune infiltrate of melanoma metastases under immune checkpoint inhibition. (2017) (0)
- 660PFirst-in-human study of IMAB362, an anti-claudin 18.2 monoclonal antibody, in patients with advanced gastroesophageal cancer (2017) (0)
- Identifying surface-associated antigens for tumor diagnosis and therapy (2003) (0)
- Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses (2021) (0)
- Evaluation of the MammaTyper® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes. (2018) (0)
- Abstract 1846: DuoBody-CD40×4-1BB (GEN1042) induces dendritic-cell maturation and enhances T-cell activation and effector functionsin vitroby conditional CD40 and 4-1BB agonist activity (2021) (0)
- Is R-CODOX-M/IVAC Inferior to Other Regimens in Burkitt’s Lymphoma: A Single Center Experience (2014) (0)
- 3D Melanoma Cocultures as Improved Models for Nanoparticle-Mediated Delivery of RNA to Tumors (2022) (0)
- Monoclonal antibodies to gt468 for treating cancer (2008) (0)
- Marker in Human Solid Tumors C as a Compatible Prognostic κ Identifies Stromal Immunoglobulin A Comprehensive Analysis of Human Gene Expression Profiles (2012) (0)
- Validation of the MammaTyper® pathological complete response (pCR)-score as a predictor for response after neoadjuvant chemotherapy (NACT) in patients with early breast cancer (BC). (2018) (0)
- Abstract 1778: Preclinical characterization of the safety and antitumor activity of IMAB027-vcMMAE, an anticlaudin 6 antibody-drug conjugate (2018) (0)
- MelanomaTumor-Reactive CTL Infiltrating Metastatic SSX-2-Derived Epitope Recognized by Proteasome-Assisted Identification of a (2002) (0)
- Oxaliplatin-induced Autoimmune Hemolitic Anemia (2017) (0)
- Determination of Polycyclic Aromatic Hydrocarbons (PAHS) in Sewage Sludge and Compost by Dispersive Solid-Phase Microextraction (SPME) and Ultra-High Performance Liquid Chromatography (UHPLC) with Diode Array Detection (DAD) (2022) (0)
- Anti-GT468 monoclonal antibodies for cancer treatment (2009) (0)
- Abstract B040: Oncolytic measles virus for tumor vaccination (2016) (0)
- Activating Polyfunctional CD8+ T Cells in Mycobacterium tuberculosis Antigens Genome-Based In Silico Identification of New (2013) (0)
- ASSESSMENT OF ETIOLOGIC FACTORS IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER: SERUM LEVELS OF BORON AND SELENIUM - (2014) (0)
- The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection (2023) (0)
- Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors (2021) (0)
- Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer (2023) (0)
- Hybrid core-shell particles for mRNA systemic delivery. (2022) (0)
- Monoclonal anti-gt468-antibodies in the treatment of cancer (2009) (0)
- Association of the neutrophil to lymphocyte ratio with survival patients with in metastatic breast cancer. (2013) (0)
- The SCID Mouse as a Model for Effective Immunotherapy of Hodgkin’s Lymphoma (1996) (0)
- Introducing Model Inversion Attacks on Automatic Speaker Recognition (2022) (0)
- The Efficacy of Tyrosine Kinase Inhibitors with Steroid As First Line Induction Therapy in Ph+ Acute Lymphoblastic Leukemia (2014) (0)
- ’ s response to reviews Title : HLA and proteasome expression body map (2018) (0)
- TCR-engineered reference samples (TERS) to control T-Cell assay performance: towards an immuno-control kit (2014) (0)
- A Fast, Flexible and Low Cost Process for Neo-Epitope Based Immune Monitoring (2017) (0)
- Abstract P1-06-11: Prediction of oncotype DX® results based on local gene expression measurements by MammaTyper® (2018) (0)
- Challenges towards the realization of individualized cancer vaccines (2018) (0)
- Abstract 763: PLAC1 interacts with FGF7 and promotes phosphorylation of FGFR2 and AKT (2018) (0)
- Under Adverse Conditions Integrin Fibronectin Receptor Promotes Tumor Cell Survival 1 β 5 α ERBB 2-Mediated Transcriptional Up-regulation of the Updated (2006) (0)
- USE OF FILT3 LGAND FOR ENHANCING MMUNE RESPONSES IN RNA MMUNIZATION (2017) (0)
- Investigation of tumor-reactive T-cell repertoire in the immune infiltrate of metastatic melanoma under immune checkpoint inhibition (2016) (0)
- Induction of immunosuppressive functions and NF-κB by FLIP in monocytes (2018) (0)
- Abstract P2-07-08: Standardized prediction of Oncotype DX®risk classes by local RT-qPCR (2019) (0)
- HLA and proteasome expression body map (2018) (0)
- A method to detect the presence of cancer in a sample to be determined by detection of the expression of a SSX-2 gene and peptide thereof (1999) (0)
- Image Compression With Learned Lifting-Based DWT and Learned Tree-Based Entropy Models (2022) (0)
- Immunity to mycobacterial infection (PP-061) (2010) (0)
- ATIM-20. GAPVAC-101 TRIAL OF A HIGHLY PERSONALIZED PEPTIDE VACCINATION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2018) (0)
- Use of flt3-ligand to amplification of immune responses by RNA immunization (2009) (0)
- Clinical Reflection of Immunophenotyping in Paroxysmal Nocturnal Hemoglobinuria: Experience of a Single Center (2014) (0)
- Abstract A004: Systemic RNA vaccines: Connecting effective cancer immunotherapy with antiviral defense mechanisms (2016) (0)
- Mechanisms of T-lymphocyte activation and cytotoxicity against human tumors induced by bispecific antibodies (2007) (0)
- Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens (2016) (0)
- OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation (2020) (0)
- Author's response to reviews Title:NCOA3 is a selective co-activator of estrogen receptor alpha - mediated transactivation of PLAC1 in MCF-7 breast cancer cells Authors: (2013) (0)
- MONGOLIAN MILITARY TERMINOLOGY IN ARABIC LETTER MULTILINGUAL DICTIONARIES (2022) (0)
- This information is current as Cell Assays Their Use To Control the Performance of T Generation of TCR-Engineered T Cells and (2015) (0)
- 786 Dose selection for DuoBody®-PD-L1×4-1BB (GEN1046) using a semimechanistic pharmacokinetics/pharmacodynamics model that leverages preclinical and clinical data (2021) (0)
- clinical Characteristics and Frequency of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation : p631 (2016) (0)
- Author's response to reviews Title:NCOA3 is a selective co-activator of estrogen receptor alpha - mediated transactivation of PLAC1 in MCF-7 breast cancer cells Authors: (2013) (0)
- 1208 DuoBody®-PD-L1x4–1BB (GEN1046) reverses T-cell exhaustionin vitro (2022) (0)
- Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds (2023) (0)
- Two states uniform 2D linear cellular automata and some replicating patterns (2020) (0)
- Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. (2019) (0)
- Determination of Cu, Cd, Mn, Fe, Zn, Pb, and Ni in urine samples by application of cobalt-diethyldithiocarbamate coprecipitation (1998) (0)
- Abstract 3741: Antimetastatic activity of ISTH0047, a potent and selective TGF-beta 2 antisense oligonucleotide, in syngeneic lung metastatic model of mouse 4T1 mammary carcinoma (2016) (0)
- Identification of cell surface antigens associated with tumor diagnosis and therapy for (2004) (0)
- Advanced Vaccine Research Methods for the Decade of Vaccines (2015) (0)
- Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial (2022) (0)
- Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy (2019) (0)
- Recombinant vaccines and the use of these (2004) (0)
- 700 LuCa-MERIT-1: First-in-human open label dose confirmation trial evaluating safety, tolerability, and efficacy of BNT116 alone and in combinations in patients with advanced non-small cell lung cancer (2022) (0)
- 2D periodic CA rules over $\mathbb{Z}_{2}$ and applications of image processing (2020) (0)
- efficacy and T-cell stimulatory capacity of dendritic cells Modification of antigen encoding RNA increases stability, translational (2013) (0)
- Racing for a SARS‐CoV‐2 vaccine (2021) (0)
- Abstract IA46: Towards implementation of T-cell therapy in pancreatic cancer (2016) (0)
- TRON Expression Atlas (TEA): a web-based platform for archival, retrieval, filtering and visualization of high throughput gene expression profiles (2014) (0)
- Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients (2022) (0)
- Comparing immunohistochemistry with RT-qPCR results in FFPE breast cancer samples for MammaTyper® cutoff verification (2019) (0)
- Recombinant vaccines and their use (2003) (0)
- Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. (2019) (0)
- The Impact of Pre-transplant Serum Ferritin on Outcomes of Allogeneic Transplantation for Acute Leukemia (2019) (0)
- 516 Peripheral and tumoral immune activity in the expansion part of the first-in-human DuoBody®-PD-L1×4–1BB (GEN1046) trial (2021) (0)
- Isolated MHC class II-binding peptide, and their use (2000) (0)
- MO24-1 Phase I/IIa trial evaluating safety and clinical activity of DuoBody®-PD-L1×4-1BB (GEN1046) in advanced solid tumors (2021) (0)
- BioTidesTM as High Throughput Screening Tool for the Identification of Antibody Binding Sites (2018) (0)
- Non-breast solid malignancies among breast cancer survivors. (2012) (0)
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma (2020) (0)
- Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. (2019) (0)
- Evaluation of Genotoxic and Apoptotic Effects of Sprouted Potato (2022) (0)
- Clinical Reflection of Immunophenotyping in Paroxysmal Nocturnal Hemoglobinuria: Experience af a Single Center (2018) (0)
- Cancer vaccines and immunotherapy: Serologically identified tumour antigens as cancer vaccines (2000) (0)
- mRNA therapeutics in cancer immunotherapy (2021) (0)
- Residual Clonal Plasma Cells Detected By Flow Cytometry at 10-4level within Autologous Stem Cell Grafts Is Associated with Significantly Less Overall Survival (2018) (0)
- OS09.9 Identification of IDH1R132H-specific T cell receptors from glioma patients and from MHC-humanized mice (2017) (0)
- Monoclonal antibodies to claudin-18 for treating cancer (2006) (0)
- Targeting the tumor vasculature with engineered cystine-knot miniproteins (2020) (0)
- Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older (2022) (0)
- 1070 HexaBody-CD27 enhances T-cell activation, proliferation, cytokine secretion and cytotoxic activity independently of Fc gamma receptor-mediated crosslinking (2022) (0)
- Automated example selection for iterative training of annotation networks (2022) (0)
- Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation (2015) (0)
- Multiple specific immunogenicity of human cancers in tge autologous host (2007) (0)
- The Effect of Pre-Transplant Psychological Well-Being on Hematological Reconstitution Following Autologous Stem Cell Transplantation in Multiple Myeloma Patients (2015) (0)
- Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (2020) (0)
- Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines (2023) (0)
- Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation (2020) (0)
- A Preliminary Analysis of Inherited Immune Checkpoint Control in Multiple Myeloma: Relative Frequency of Inhibitory or Activating Type Killer Immunoglobulin like Receptors and Their Cognate Ligands HLA-C1 and -C2 (2017) (0)
- Human Tuberculosis T Cells in + Activating Polyfunctional CD 8 Antigens Mycobacterium tuberculosis Genome-Based In Silico Identification of New Ottenhoff (2010) (0)
- METHODS FOR CHARACTERIZING LOSS OF ANTIGEN PRESENTATION (2018) (0)
- S16. Use of cancer specific gene products for diagnosis and immunointervention (2008) (0)
- Prognostic impact of CD 4-positive T cell subsets in early breast cancer (0)
- P0411 SERUM POTASSIUM (K+) ABNORMALITIES IN THE HOSPITAL SETTING: AN OBSERVATIONAL STUDY FOR CAUSES AND MANAGEMENT (2009) (0)
- OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and a prognostic gene expression signature (2019) (0)
- Tumor vaccination involving a humoral immune response, and proteins therefor including all or a portion of a hepatitis b virus core antigen protein and an epitope of claudin 18.2 (2011) (0)
- Multiple Arterial Thrombosis Related with Cantharidin Ingestion (2018) (0)
- TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression (2015) (0)
- PO-516 E6/E7 RNA(LIP): a novel liposomal RNA vaccine for treatment of patients with HPV16-positive malignancies (2018) (0)
- S2006 Comparative Whole Genome Expression Analysis in Experimental Models of Colitis Associated and Sporadic Colon Cancer (2008) (0)
- 866 A Highly Specific Cancer Target, Regulated Via Promoter Methylation (2012) (0)
- The efficacy of tyrosine kinase inhibitors with steroid in ph+ acute lymphoblastic leukemia. (2016) (0)
- PO-324 Detection of high-risk prostate cancer biomarkers by RNA sequencing and qPCR method (2018) (0)
- NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells (2013) (0)
- A phase 2 multicenter, open-label, randomized, controlled trial in patients with stage II/III colorectal cancer who are ctDNA positive following resection to compare efficacy of autogene cevumeran versus watchful waiting. (2022) (0)
- Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles (2017) (0)
- Discovery of Target Molecules for Cancer Immunotherapy by Genetic and Bioinformatic Approaches (2006) (0)
- RNA with chemotherapeutic base analogues as a dual-functional anti-cancer drug (2022) (0)
- Monoclonal antibodies to claudin-18 for the treatment of cancer (2006) (0)
- Abstract LB198: A first-in-human, open-label, multicenter study of intratumoral SAR441000 (mixture of cytokine encoding mRNAs), as monotherapy and in combination with cemiplimab in patients with advanced solid tumors (2023) (0)
- 525 Preliminary safety, PK/PD and efficacy results from a first-in-human phase I/IIa clinical trial of BNT411, a systemic Toll-like receptor 7 agonist in patients with solid tumors (2021) (0)
- Exploiting the Mutanome for Personalized Cancer Immunotherapy (2015) (0)
- biomedical research Of mice and models: improved animal models for (2015) (0)
- The Effect of Haploidentical Hematopoietic Stem Cell Transplantation on Long Term Survival in Refractory Heavily Pretreated Hematologic Diseases (2017) (0)
- Lipid nanoparticles for organ-specific delivery of RNA (2014) (0)
- Lipoprotein apheresis efficacy and challenges: single center experience (2021) (0)
- Dose determination for immunotherapeutic agents (2017) (0)
- Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunological and Clinical Outcomes Running Title: Anti-CEA DNA Fusion Vaccination (2016) (0)
- Retraction: Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma (Molecular & cellular proteomics : MCP (2018) 17 11 (2132-2145)) (2019) (0)
- Abstract P3-07-08: Comparison of MammaTyper® RT-qPCR based subtyping with simulated breast cancer prognostic signatures (2020) (0)
- Abstract 3283: GEN1046 (DuoBody®-PD-L1x4-1BB) in combination with PD-1 blockade potentiates anti-tumor immunity (2023) (0)
This paper list is powered by the following services:
Other Resources About Uğur Şahin
What Schools Are Affiliated With Uğur Şahin?
Uğur Şahin is affiliated with the following schools:
